Intracapsular Tonsillectomy in Adults
Study Details
Study Description
Brief Summary
Comparing the classical extracapsular tonsillectomy (TE) performed with electrosurgery to intracapsular approaches (SIPT) by coblation or microdebrider. The patient group is adults with recurrent or chronic tonsillitis
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
Extracapsular tonsillectomy (TE) with monopolar electrosurgery is the most commonly used approach in adult tonsil surgery in Turku University Central Hospital, Finland.
In our study setting we are comparing intracapsular tonsillectomy (subtotal/intracapsular/partial tonsillectomy (SIPT) ) as the intervention group with extracapsular tonsillectomy as the control group.
SIPT is done with either coblation or microdebrider and TE with monopolar electrosurgery.
Indications for surgery are recurrent tonsillitis or chronic tonsillitis. The patient group is adults (16-65 years)
Safety, efficiency and cost-effectiveness are monitored in a prospective, patient-blinded and randomised study setting.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Active Comparator: ECTE/Electrosurgery Extracapsular tonsillectomy (ECTE) with monopolar electrosurgery |
Procedure: tonsillectomy
removal of tonsil tissue as described in the study arms
Other Names:
|
Experimental: ICTE/Microdebrider Intracapsular tonsillectomy (ICTE) with microdebrider |
Procedure: tonsillectomy
removal of tonsil tissue as described in the study arms
Other Names:
|
Experimental: ICTE/Coblator Intrapsular tonsillectomy (ICTE) with coblator |
Procedure: tonsillectomy
removal of tonsil tissue as described in the study arms
Other Names:
|
Outcome Measures
Primary Outcome Measures
- Post-operative recovery [21 days]
Pain post-operatively after discharge as self-reported pain intensity over the past day. Each day is scored with the modified Brief Pain Inventory and recovery is achieved when pain score reaches preset values. Recovery speed defined as pain VAS-score 3 or less at rest; or pain VAS-score 5 or less without regular analgesics use. Daily questionnaire used: Brief Pain Inventory.
Secondary Outcome Measures
- Analgesics use [21 days]
Need for analgesics postoperatively during 21 days. Measured as number of naprometin tablets/ day and the number of tramadol-paracetamol combination tablets/day.
- Post-operative bleeding [21 days]
Bleeding post-operatively at the ward or at any point during 21 days. Measured as 1-4 (1= bleeding, stopped spontaneously, no contact with staff; 2: Contact with ER, bleeding stopped without intervention; 3: Bleeding, needed intervention (packing, topical adrenalin, electrosurgical hemostasis; 4: Needed OR-time, blood transfusion, ward days
- Life Quality [6 months]
Quality of life as defined by the questionnaires: Tonsillectomy Outcome Inventory 14 "TOI-14" preoperatively and 6 months after operation;
- Residual tonsil tissue [6 months]
Residual tonsil measured right after surgery is completed and at 6 months follow-up.
- Revision surgery [5 years]
The need of revision surgery after tonsillectomy, recorded with questionnaire: Nordic Tonsil Surgery Register
- Throat problems [5 years]
Throat problems as described by the Nordic Tonsil Surgery Register at different time points postoperatively
- Life quality [6 months]
Quality of life as defined by the questionnaires: Glasgow Benefit Inventory "GBI" at 6 months after operation.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Age 16-65 years
-
Planned tonsil surgery with informed consent
-
Recurrent or chronic tonsillitis
Exclusion Criteria:
-
Less than 1 month old, drained quinsy
-
Acute "hot phase" tonsillitis
-
Previous palatine tonsil surgery
-
Suspicion or confirmation of malignancy
-
High dose analgesics consumption
-
Current CPAP-device usage for treatment of OSAS
-
Untreated gastro-esophageal reflux disease
-
Anticoagulative medication
-
Any condition of hemophilia
-
Pregnancy, lactation
-
Current or positive history of malignant disease (if still active follow-up)
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | TYKS Korvaklinikka | Turku | Finland | 20521 |
Sponsors and Collaborators
- Turku University Hospital
Investigators
- Study Director: Jussi Jero, Professor, Turku University Hospital
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- T211/2018